Site Search
Professionals 160 results
Capabilities 51 results
Industry
Practice Area
Employee Benefits & Executive Compensation
With attorneys based in Chicago, New York and Washington, D.C., Winston’s Employee Benefits & Executive Compensation (EBEC) team represents a broad range of plan sponsors and offers clients not just deal support but the full suite of employee benefit services. These include public company reporting and executive compensation, employee benefits in mergers and acquisitions, qualified retirement plans and Title I investment advice, health and welfare benefit plans, employee stock ownership plans (ESOPs), and international human resources matters. And driven by a volatile labor market, we are partnering with clients to innovate plan structure and design, including cutting-edge services such as private exchange medical benefits, employee benefits in captive insurance, and fiduciary governance best practices. With decades of experience, our EBEC team maintains strong brand recognition, with clients describing our attorneys as “superb,” “very client-friendly,” “extremely responsive and able to bring forth the right resources,” and “having an “incredible breadth of knowledge.”
Practice Area
As a firm of choice for many major businesses, we represent employers, fiduciaries, boards of directors, benefit plans, and plan administrators in all aspects of ERISA litigation, including claims relating to fiduciary liability, plan investments, excessive fees, plan qualification, plan termination, reversion of excess assets, retiree medical benefits, severance and employment contract matters, tax liability matters, and retirement and welfare benefit claims.
Experience 38 results
Experience
|January 22, 2026
Advised SQM on US$600M offering of subordinated capital notes due 2056 (Hybrid Bond Offering)
Winston & Strawn LLP advised longstanding client Sociedad Química y Minera de Chile S.A. (“SQM”) (NYSE: SQM) on its US$600 million offering of subordinated capital notes. The notes were offered in the United States pursuant to Rule 144A and outside the United States pursuant to Regulation S.The subordinated capital notes are due in 2056 and constitute SQM’s first international hybrid bond issuance, structured to be consistent with SQM’s recent UF 10 million (approximately US$ 430 million) Series S hybrid-subordinated bond issuance in the Chilean securities market. The notes bear an initial annual interest rate of 5.625% and are subject to reset on April 22, 2031 (the “First Reset Date”), and on every fifth anniversary thereafter, based on a spread over the 5-year U.S. Treasury bond rate, with interest rate step-ups on the fifth and twentieth anniversaries of the First Reset Date. The transaction closed on January 22, 2026.BofA Securities, Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Santander US Capital Markets LLC, and Scotia Capital (USA) Inc. acted as initial purchasers of the notes.Link Capital Partners was financial advisor to SQM.SQM is a global company with a leading position in the lithium, iodine, and potassium nitrate markets. It develops and produces a diverse range of products for industries essential to human progress, including health, nutrition, renewable energy, and technology, driven by innovation and technological development.The Winston & Strawn team advising on the transaction included corporate partner Sey-Hyo Lee (New York) and foreign legal advisor Bruno M. Fiorino (New York). Partner Katherine Erbeznik (New York) advised on tax matters.
Experience
|April 11, 2025
Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering
Winston & Strawn is serving as underwriters counsel to R.F. Lafferty in connection with Cuprina Holdings, a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds as well as cosmeceuticals for the health and beauty sector, in its announced closing of $12,000,000 initial public offering. The Offering consists of 3,000,000 ordinary shares at a public offering price of $4 per share, for total gross proceeds of $12,000,000, before deducting underwriting discounts and offering expenses.
Experience
|November 11, 2024
A team led by Craig Godshall and Matthew Schlosser represented Court Square Capital Partners, a New York-based leading middle-market private equity company, in its entry into a definitive agreement to sell Advanced Diabetes Supply® Group, a California-based national distributor of Durable Medical Equipment specializing in diabetes supplies, to Cardinal Health for US$1.1B. This sale will allow ADSG to continue to expand its reach and enhance the way it serves its approximately 500,000 patients nationwide with advances in in-home delivery of diabetes products including continuous glucose monitoring devices and other testing supplies.
Insights & News 1,210 results
Benefits Blast
|February 17, 2026
|9 Min Read
Recent developments at the federal legislative and regulatory levels signal a significant shift toward greater transparency requirements in the pharmacy benefit management (PBM) industry.
Benefits Blast
|February 3, 2026
|3 Min Read
Group Health Plans Must Update HIPAA Notices by February 16 to Address New SUD Privacy Rules
Covered entities, including group health plans, must update and distribute their Health Insurance Portability and Accountability Act of 1996 (HIPAA) Notice of Privacy Practices (NPP) by February 16, 2026, to comply with new rules for handling substance use disorder ) records.
Recognitions
|January 29, 2026
|1 Min Read
Winston Paris Teams Win Both Gold Healthcare Trophies at Le Sommet du Droit 2026
Organized by Décideurs Juridique, the Sommet du Droit awards ceremony was held on January 29, 2026, marking its twenty-sixth consecutive year.
Other Results 38 results
Site Content
What Is Healthcare Security Law?
The Health Insurance Portability and Accountability Act of 1996 (HIPAA) established U.S. regulations to protect the privacy and security of individual health information. The healthcare security law creates these specific protections through both the HIPAA Privacy Rule and the HIPAA Security Rule. The Privacy Rule has set national standards for the protection of certain types of health information. The Security Rule established security standards for protecting consumers’ health information that is stored or transferred electronically. The healthcare Security Rule outlines the operational safeguards that organizations must implement to keep protected electronic health information secure.
Site Content
What Is Healthcare Privacy Law?
Today, healthcare privacy law is driven by the 1996 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule. This federal privacy rule establishes protections for specific patient health information. Healthcare plans, clearinghouses, and providers are subject to the law.
Site Content